Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | Case report

Esomeprazole/methylprednisolone/pembrolizumab

Haemorrhagic gastritis, delayed hepatitis and lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Otsuka T, et al. Checkpoint inhibitor-induced gastritis followed by delayed severe hepatitis in a patient with lung metastases of head and neck squamous cell carcinoma: a case report. Frontiers in Oncology 13: Jan 2023. Available from: URL: http://www.frontiersin.org/Oncology/about Otsuka T, et al. Checkpoint inhibitor-induced gastritis followed by delayed severe hepatitis in a patient with lung metastases of head and neck squamous cell carcinoma: a case report. Frontiers in Oncology 13: Jan 2023. Available from: URL: http://​www.​frontiersin.​org/​Oncology/​about
Metadaten
Titel
Esomeprazole/methylprednisolone/pembrolizumab
Haemorrhagic gastritis, delayed hepatitis and lack of efficacy: case report
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41853-y

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Pembrolizumab

Case report

Lenalidomide

Case report

Multiple drugs

Case report

Rivaroxaban